Nationwide Implementation of Standardized Structured Reporting

Standardized Structured Reporting Clinical Trial

— IMPROVING  

Official title:

Nationwide Implementation of Standardized Structured Reporting to Support Optimal Treatment Decisions

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03649126
• Other study ID #: KWF-8281
• Secondary ID: 2018-4124
• Status: Not yet recruiting
• Start date: August 21, 2018
• Est. completion date: June 30, 2020

Study information

• Verified date: August 2018
• Source: Radboud University
• Contact: Julie Swillens, MSc
• Phone: +31-615343689
• Email: Julie.Swillens[@]radboudumc.nl
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The first objective is to explore factors that impede or facilitate implementation of SSR in pathology (and other disciplines) among the MDT members receiving SSRs. The second objective is to select, develop and evaluate (process and effect outcomes) implementation tools supporting optimal implementation of SSR in pathology. The third objective is to offer implementation tools to all pathology laboratories in the Netherlands and to share the SSR-kit for successful implementation with other medical disciplines

Description:

By implementing SSR in various disciplines, we contribute to improving communication, efficiency and quality of multidisciplinary team (MDT) meetings and facilitate optimal treatment decision making. Optimal discussion of each patient at MDT meetings can be achieved by a clear communication of all diagnostic results among MDT members. However, the adoption of innovations, such as SSR, is laborious, especially when the innovation requires changing daily habits. Offering implementation tools supports the adoption of innovations among medical professionals. Implementation tools are most effective when they are developed on the basis of factors that impede or facilitate the innovation. Besides the importance of investigating these factors for SSR among pathologists, we will also involve MDT members receiving pathology SSRs in our study. After all, because MDT members will greatly benefit from SSR, they could play a key role in stimulating the use of SSR among pathologists. Therefore, we will also explore which tools MDT members need to stimulate the diagnostic disciplines in using SSR. Subsequently, we will develop and evaluate implementation tools to support the use of SSR by pathologists. The kit for successful implementation of SSR will be offered to other medical disciplines like radiology, endoscopy, and surgery who face similar challenges with implementation of SSR. The SSR-kit consists of our multidisciplinary approach for the whole process of developing implementation tools for SSR, examples of tools for SSR, and other results of this project.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: June 30, 2020
• Est. primary completion date: June 30, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 68 Years

Eligibility

Inclusion Criteria:

• Pathologists of urological, gynecological or gastro-intestinal cancers

• Other MDT-members of urological, gynecological or gastro-intestinal cancers (medical oncologists, radiologists, radiotherapists, urologists, gynecologists, intestinal surgeons, nuclear medicine physicians, nurse practitioners).

• Dutch

• Residents

Exclusion Criteria:

• Retirees

Related Conditions & MeSH terms

• Standardized Structured Reporting

Intervention

Behavioral:
• Implementation tools
Implementation tools developed by experts in order to increase the use of SSR in pathology

Locations

Country	Name	City	State
Netherlands	Radboud University Nijmegen Medical Center	Nijmegen	Gelderland

Sponsors (3)

Lead Sponsor	Collaborator
Radboud University	Dutch Cancer Society, PALGA foundation

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Barriers and facilitators in implementation of SSR in MDT - focus groups and self-developed questionnaire	Barriers and facilitators in implementation of SSR among MDT members measured by focus groups and a self-developed questionnaire	9 months
Primary	Effectiveness of implementation tools - frequencies of use of SSR templates in pathology in the Netherlands	The improvement in use of SSR templates in the Netherlands (=effectiveness of implementation tools) measured by frequencies of use of SSR templates in pathology (=all laboratories in the Netherlands)	6 months
Secondary	Determinants of barriers and facilitators in implementation of SSR - focus groups and a self-developed questionnaire	Determinants of barriers and facilitators in implementation of SSR among MDT members measured by focus groups and a self-developed questionnaire	1 month
Secondary	Experiences with implementation tools - questionnaire	Experiences of pathologists and other MDT members with the implementation tools, measured by a questionnaire	6 months
Secondary	Use of implementation tools - questionnaire	Use of implementation tools among pathologists and other MDT members, measured by a questionnaire	6 months